<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-3124694753969372940</id><updated>2011-07-30T11:13:25.856-07:00</updated><category term='GEOmarketing'/><category term='what’s in it for pharma?'/><title type='text'>IM Associates Blog</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>7</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-2683820336461134163</id><published>2010-06-15T02:26:00.001-07:00</published><updated>2010-06-15T02:26:45.678-07:00</updated><title type='text'>Patient flow enabled forecasting</title><content type='html'>Check out this SlideShare Presentation: &lt;div style="width:425px" id="__ss_4504184"&gt;&lt;strong style="display:block;margin:12px 0 4px"&gt;&lt;a href="http://www.slideshare.net/IMAssociates/patient-flow-enabled-forecasting" title="Patient flow enabled forecasting"&gt;Patient flow enabled forecasting&lt;/a&gt;&lt;/strong&gt;&lt;object id="__sse4504184" width="425" height="355"&gt;&lt;param name="movie" value="http://static.slidesharecdn.com/swf/ssplayer2.swf?doc=20100611patient-flowenabledforecasting-100615040619-phpapp02&amp;stripped_title=patient-flow-enabled-forecasting" /&gt;&lt;param name="allowFullScreen" value="true"/&gt;&lt;param name="allowScriptAccess" value="always"/&gt;&lt;embed name="__sse4504184" src="http://static.slidesharecdn.com/swf/ssplayer2.swf?doc=20100611patient-flowenabledforecasting-100615040619-phpapp02&amp;stripped_title=patient-flow-enabled-forecasting" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="425" height="355"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;div style="padding:5px 0 12px"&gt;View more &lt;a href="http://www.slideshare.net/"&gt;presentations&lt;/a&gt; from &lt;a href="http://www.slideshare.net/IMAssociates"&gt;IM Associates&lt;/a&gt;.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-2683820336461134163?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/2683820336461134163/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2010/06/patient-flow-enabled-forecasting.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/2683820336461134163'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/2683820336461134163'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2010/06/patient-flow-enabled-forecasting.html' title='Patient flow enabled forecasting'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-4170815928102228471</id><published>2010-05-04T07:58:00.000-07:00</published><updated>2010-05-04T08:22:48.029-07:00</updated><title type='text'>Belgische onderneming als katalysator richting de nieuwe farmaceutische “Commercial Models”.</title><content type='html'>&lt;span style="font-weight: bold;"&gt;Het huidige commerciële model van farmaceutische bedrijven staat onder druk, en niet alleen bij ons maar ook in de nieuwe groeilanden. Een Belgische oplossingenleverancier, IM Associates, activeert farmaceutische bedrijven overal ter wereld in hun zoektocht naar een nieuwe marktbenadering.&lt;/span&gt;&lt;br /&gt;&lt;p&gt;De healthcare industrie in zowel Europa als in de nieuwe groeilanden (China, Rusland, India, en Latijns Amerika) staat aan de start van een uitdagende reis richting “New Commercial Model”. Het besef dat het huidige commerciële model binnen de healthcare industrie niet is aangepast aan de marktrealiteit en de uitdagingen voor deze industrie in de toekomst, begint stilaan zijn ingang te vinden. Uiteraard is het uitgangspunt in Europa versus de nieuwe groeilanden totaal verschillend:&lt;br /&gt;&lt;br /&gt;In Europa wordt de “voorgeschreven” gezondheidszorg grotendeels betaald door de overheid en vanuit deze positie beschouwt men besparingen in de kosten van geneesmiddelen als eerste bron van een mogelijke sanering van de publieke financiën. Vanuit de pers, academische wereld, verschillende zorgverstrekkers en publieke opinie wordt de industrie continu onder vuur genomen. Allerlei initiatieven worden ondernomen die een invloed hebben op de rol van de artsen, verzekeringsinstellingen, commissies, apothekers of andere distributiekanalen, ongeacht of we spreken van een omgeving van voorschriftproducten of producten vrij van voorschrift. Het is in Europa dan ook van groot belang om het klassieke healthcare business model te verlaten en op zoek te gaan naar een commerciële aanpak in het belang van alle stakeholders (dus ook patiënt, zorgverstrekkers en overheid).&lt;br /&gt;&lt;br /&gt;Voor de nieuwe groeilanden is het van belang om zo snel mogelijk een gestructureerde benadering op poten te zetten binnen heel uitgestrekte, onoverzichtelijke en uitermate snel evoluerende markten. Daarenboven heeft men te maken met locale culturen, waar er heel vaak nog een beroep gedaan wordt op traditionele locale producten. De resultaten die in deze gebieden gerealiseerd worden, moeten de nodige fondsen genereren voor het toekomstige onderzoek en ontwikkeling binnen de healthcare industrie. Daarom worden er heel ambitieuze commerciële doelstellingen gezet voor locale management teams. Het opzetten van een uitermate flexibel commercieel model is dan ook onontbeerlijk.&lt;br /&gt;&lt;br /&gt;Sinds 1997, doen laboratoria zoals Boehringer Ingelheim, Bayer, Omega Pharma, GSK, Wyeth, … een beroep op IM Associates als katalysator om richting deze nieuwe commercial models te evolueren, zowel binnen Europa als in de opkomende economieën van Zuid-Amerika, China &amp;amp; Rusland. Vandaag heeft 60% van het verleende advies betrekking op buitenlandse projecten. In 2010 heeft IM Associates dan ook succesvol haar filialen in Frankrijk en Duitsland geopend om alvast de Duitse en Franse laboratoria op hun locale markten nog sneller te laten evolueren richting het voorziene toekomstmodel. Volgende prioriteit wordt een locale aanwezigheid in Rusland, China en Latijns Amerika.&lt;br /&gt;&lt;br /&gt;&lt;i&gt;IM Associates is een Leuvense leverancier van oplossingen die zich toespitst op de healthcare industrie. IM Associates helpt zijn klanten overal ter wereld met het aanpassen van hun commercieel model om zo hun rentabiliteit te verhogen.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;&lt;i&gt;&lt;b&gt;Voor verdere informatie kan u contact opnemen met Thomas Euben, verantwoordelijke externe relaties bij IM Associates op 016/22.47.43 of bezoek onze website: &lt;a href="http://www.im-associates.eu"&gt;www.im-associates.eu&lt;/a&gt;.&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-4170815928102228471?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/4170815928102228471/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2010/05/belgische-onderneming-als-katalysator.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/4170815928102228471'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/4170815928102228471'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2010/05/belgische-onderneming-als-katalysator.html' title='Belgische onderneming als katalysator richting de nieuwe farmaceutische “Commercial Models”.'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-2069705117093266619</id><published>2009-11-04T03:04:00.000-08:00</published><updated>2009-11-04T03:14:51.335-08:00</updated><title type='text'>IM Associates Media Channel on Youtube</title><content type='html'>&lt;p&gt;IM Associates is now on youtube. For the moment, you can enjoy some movies related to our services. In the future, you'll find our tutorials on this media space. &lt;br&gt;&lt;br /&gt;Visit our Youtube page now &lt;a href="http://www.youtube.com/IMassociatesmedia"&gt;www.youtube.com/IMassociatesmedia&lt;/a&gt; &lt;/P&gt;&lt;br /&gt;&lt;object width="425" height="344"&gt;&lt;param name="movie" value="http://www.youtube.com/v/DSw48fZ1aoA&amp;amp;hl=en&amp;amp;fs=1&amp;amp;"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowscriptaccess" value="always"&gt;&lt;embed src="http://www.youtube.com/v/DSw48fZ1aoA&amp;amp;hl=en&amp;amp;fs=1&amp;amp;" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-2069705117093266619?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/2069705117093266619/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2009/11/im-associates-media-channel-on-youtube.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/2069705117093266619'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/2069705117093266619'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2009/11/im-associates-media-channel-on-youtube.html' title='IM Associates Media Channel on Youtube'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-7893862487611262912</id><published>2009-10-23T07:04:00.000-07:00</published><updated>2009-10-23T07:09:22.624-07:00</updated><title type='text'>CODIMP Consumer Healthcare Lunch</title><content type='html'>The Codimp Steering Committee, with the support of IM Associates &amp; Across Health, organizes the CODIMP Consumer Healthcare Lunch on the occasion of it general meeting. This lunch will take place on November 27th in the Arenberg restaurant, kapeldreef 46 à Heverlee (Egenhoven). You are invited from 11u30 to enjoy an appetizer. The lunch will start at 12h prompt (the end is at 14h). After this lunch we are pleased to offer you the opportunity to network in a relaxing atmosphere.&lt;br /&gt;&lt;br /&gt;&lt;b&gt;The menu: &lt;/B&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;State of affairs within CODIMP clarified by Mr.. Miel Hellemond (Johnson &amp; Johnson Consumer Care; president Steering Committee CODIMP)&lt;br /&gt;&lt;li&gt;Integrated multichannel strategy in Consumer Healthcare: Brave New World?  By mr. Fonny Schenck (Across Health) &lt;br /&gt;&lt;li&gt;How to implement GEOmarketing and Consumer Data in Consumer Healthcare by mr. Bart Bierinckx (IM Associates)&lt;br /&gt;&lt;li&gt;Networking drink&lt;/ul&gt;&lt;br /&gt;If you want to register, please contact Thomas Euben (teuben@im-associates.be).&lt;br /&gt;&lt;br /&gt;We hope to welcome you!&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-7893862487611262912?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/7893862487611262912/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2009/10/codimp-consumer-healthcare-lunch.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/7893862487611262912'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/7893862487611262912'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2009/10/codimp-consumer-healthcare-lunch.html' title='CODIMP Consumer Healthcare Lunch'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-4548657193941942815</id><published>2009-10-20T03:28:00.001-07:00</published><updated>2009-10-20T03:28:19.349-07:00</updated><title type='text'>GEOmarketing what's in it for pharma?</title><content type='html'>Discover the future in sales and marketing excellence by applying GEOmarketing.&lt;div style="width:425px;text-align:left" id="__ss_2231825"&gt;&lt;a style="font:14px Helvetica,Arial,Sans-serif;display:block;margin:12px 0 3px 0;text-decoration:underline;" href="http://www.slideshare.net/IMAssociates/geomarketing-whats-in-it-for-pharma" title="GEOmarketing what&amp;#39;s in it for pharma?"&gt;GEOmarketing what&amp;#39;s in it for pharma?&lt;/a&gt;&lt;object style="margin:0px" width="425" height="355"&gt;&lt;param name="movie" value="http://static.slidesharecdn.com/swf/ssplayer2.swf?doc=20091009geomarketingwhatsinitforpharma-091015094554-phpapp02&amp;stripped_title=geomarketing-whats-in-it-for-pharma" /&gt;&lt;param name="allowFullScreen" value="true"/&gt;&lt;param name="allowScriptAccess" value="always"/&gt;&lt;embed src="http://static.slidesharecdn.com/swf/ssplayer2.swf?doc=20091009geomarketingwhatsinitforpharma-091015094554-phpapp02&amp;stripped_title=geomarketing-whats-in-it-for-pharma" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="425" height="355"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;div style="font-size:11px;font-family:tahoma,arial;height:26px;padding-top:2px;"&gt;View more &lt;a style="text-decoration:underline;" href="http://www.slideshare.net/"&gt;documents&lt;/a&gt; from &lt;a style="text-decoration:underline;" href="http://www.slideshare.net/IMAssociates"&gt;IM Associates&lt;/a&gt;.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-4548657193941942815?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/4548657193941942815/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2009/10/geomarketing-what-in-it-for-pharma.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/4548657193941942815'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/4548657193941942815'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2009/10/geomarketing-what-in-it-for-pharma.html' title='GEOmarketing what&amp;#39;s in it for pharma?'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-2927775312332074488</id><published>2009-09-21T09:06:00.000-07:00</published><updated>2009-09-21T09:07:42.513-07:00</updated><title type='text'>Durven groeien, zelfs in crisis</title><content type='html'>&lt;span style="font-style:italic;"&gt;&lt;span style="font-weight:bold;"&gt;De laatste maanden stonden de kranten vol met negatieve berichten over de crisis. Bedrijfssluitingen, herstructureringen en productieverminderingen leken het nieuws te domineren. In deze berichtgeving was er weinig ruimte voor positieve verhalen. Toch zijn er bedrijven die er in slagen om in deze “moeilijk” tijden te groeien, aan marktexpansie te doen en die volluit durven te ondernemen. De Leuvense adviesverlener IM Associates is een mooi voorbeeld van succes in tijden van crisis.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Groeiende KMO&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Ondanks het feit dat de Belgische economie achteruitging en de werkloosheid sterk steeg, heeft een klein bedrijf als IM Associates uit Leuven een jaar van succes gekend: een omzetgroei van 25% tot 1.9 miljoen euro, een personeelsgroei van 75% (Van 8 naar 14 werknemers) en het openen van een kantoor in Parijs en in Düsseldorf. &lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Het driedimensionaal IM Associates recept: specialisatie, excellentie en klanten loyaliteit&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Het recept voor de succesvolle groei is duidelijk; IM Associates heeft geopteerd voor een doorgedreven specialisatie in een nichemarkt: adviesverlening omtrent sales &amp; marketing excellence binnen de farmaceutische industrie. Als Belgische KMO maken zij het verschil bij grote farmaceuten zoals Boehringer Ingelheim, GSK of Bayer. Bij deze bedrijven is IM Associates verantwoordelijk voor het opzetten van Sales en Marketing excellence trajecten, wereldwijd. &lt;br /&gt;&lt;br /&gt;Excellentie is een ander basisingrediënt. Er mag geen enkele toegift gedaan worden inzake kwaliteit van de geleverde diensten.  Hierdoor bouwt IM Associates vertrouwen op met zijn klanten. Excellent of overtreffend zijn is dan ook de basisvoorwaarde van alle teamleden, en de opvolging ervan behoort tot de persoonlijke doelstellingen van het management.&lt;br /&gt;&lt;br /&gt;De bovenstaande no nonsense aanpak leidt tot de heel belangrijke klanten loyaliteit: in een periode waarin potentiële klanten het moeilijk hebben om de implementatie van nieuwe projecten te verdedigen, zijn de bestaande klanten de belangrijkste bron voor verdere innovatie, ontwikkeling van de organisatie en groei.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Wereldwijd vanuit Leuven&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Het IM Associates team wordt wereldwijd ingezet. Door de ervaring in farmaceutische markten in landen zoals Mexico, China, Rusland, Turkije, Polen, … heeft IM Associates zich ontwikkeld als strategische partner van farmaceutische bedrijven die binnen deze “emerging” markets hun groeipotentieel willen realiseren. Ook de veranderende business modellen voor de farma industrie binnen de Europese markten maken een alledaags onderdeel uit van de projecten die vanuit Leuven gestuurd worden. De slankheid van het bedrijf, de typische flexibiliteit van een KMO en de investering in de juiste technologieën, zijn de motoren van groei in woelige tijden.&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;&lt;br /&gt;Positief ondernemen&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;IM Associates is lang niet het enige Belgische bedrijf dat zo een parcours heeft afgelegd de laatste maanden. Vele Belgische KMO’s hebben in tijden van crisis juist een vuist gemaakt. Zij hebben zich kunnen uitbouwen met een doorgedreven ondernemerszin en een positieve ingesteldheid ondanks de vaak onheilspellende economische berichtgeving. Nochtans is dit positivisme broodnodig om mensen te motiveren om te ondernemen en te blijven investeren.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-2927775312332074488?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/2927775312332074488/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2009/09/durven-groeien-zelfs-in-crisis.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/2927775312332074488'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/2927775312332074488'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2009/09/durven-groeien-zelfs-in-crisis.html' title='Durven groeien, zelfs in crisis'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3124694753969372940.post-1765054861427538056</id><published>2009-09-09T08:45:00.000-07:00</published><updated>2009-09-09T09:15:29.362-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='what’s in it for pharma?'/><category scheme='http://www.blogger.com/atom/ns#' term='GEOmarketing'/><title type='text'>GEOmarketing Lunch</title><content type='html'>&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5Cteuben%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CDOCUME%7E1%5Cteuben%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CDOCUME%7E1%5Cteuben%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;ZH-CN&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:SimSun; 	panose-1:2 1 6 0 3 1 1 1 1 1; 	mso-font-alt:宋体; 	mso-font-charset:134; 	mso-generic-font-family:auto; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:1 135135232 16 0 262144 0;} @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;} @font-face 	{font-family:"\@SimSun"; 	panose-1:0 0 0 0 0 0 0 0 0 0; 	mso-font-charset:134; 	mso-generic-font-family:auto; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:1 135135232 16 0 262144 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	mso-bidi-font-size:10.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman"; 	mso-ansi-language:FR; 	mso-fareast-language:NL;} p 	{mso-style-priority:99; 	mso-margin-top-alt:auto; 	margin-right:0cm; 	mso-margin-bottom-alt:auto; 	margin-left:0cm; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:SimSun;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:10.0pt; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt;} @page Section1 	{size:612.0pt 792.0pt; 	margin:70.85pt 70.85pt 70.85pt 70.85pt; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:SimSun; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;p style="margin: 1pt 0cm; text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;ZH-CN&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:SimSun; 	panose-1:2 1 6 0 3 1 1 1 1 1; 	mso-font-alt:"Arial Unicode MS"; 	mso-font-charset:134; 	mso-generic-font-family:auto; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:1 135135232 16 0 262144 0;} @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-alt:"Arial Rounded MT Bold"; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;} @font-face 	{font-family:Tahoma; 	panose-1:2 11 6 4 3 5 4 4 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:1627400839 -2147483648 8 0 66047 0;} @font-face 	{font-family:"\@SimSun"; 	mso-font-charset:134; 	mso-generic-font-family:auto; 	mso-font-pitch:auto; 	mso-font-signature:1 135135232 16 0 262144 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-fareast-font-family:SimSun; 	mso-fareast-theme-font:minor-fareast; 	mso-bidi-font-family:"Times New Roman";} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:10.0pt; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt;} @page Section1 	{size:612.0pt 792.0pt; 	margin:70.85pt 70.85pt 70.85pt 70.85pt; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:SimSun; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;/p&gt;&lt;span style="font-size:85%;"&gt;IM Associates is pleased to invite you for the lunch meeting: “GEOmarketing, what’s in it for pharma?” on October 9, 2009 in restaurant Arenberg in Heverlee (Leuven).&lt;br /&gt;&lt;br /&gt;Our team welcomes you at our information stands from 11 am for a personal introduction to the topic GeoMarketing. Between 12h and 14h, a lunch combined with powerful presentations on the possibilities of geo-marketing for the pharmaceutical industry will take place. "The low hanging fruits at one glance", "Designing optimal territories” and the results of the study" “GEOmarketing in belgian pharmaceutical companies”, are the three themes which we will raise. Starting from 14h, you can again visit our information stands for a definite answer to your questions.&lt;br /&gt;&lt;br /&gt;To participate in the lunch meeting, please subscribe as soon as possible (limited number of places!) via e-mail to teuben@im-associates.be.&lt;br /&gt;&lt;br /&gt;Participating in the study "geomarketing in Belgian pharmaceutical companies" is possible by browsing to &lt;a href="http://survey.im-associates.be/"&gt;http://survey.im-associates.be&lt;/a&gt;. All participants to the study will receive a personal presentation of the results and have the possibility to win a Garmin outdoor GPS device .&lt;br /&gt;&lt;/span&gt;&lt;p style="margin: 1pt 0cm; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:10;"  &gt;&lt;br /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3124694753969372940-1765054861427538056?l=im-associates.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://im-associates.blogspot.com/feeds/1765054861427538056/comments/default' title='Reacties plaatsen'/><link rel='replies' type='text/html' href='http://im-associates.blogspot.com/2009/09/geomarketing-lunch.html#comment-form' title='0 reacties'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/1765054861427538056'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3124694753969372940/posts/default/1765054861427538056'/><link rel='alternate' type='text/html' href='http://im-associates.blogspot.com/2009/09/geomarketing-lunch.html' title='GEOmarketing Lunch'/><author><name>IM Associates</name><uri>http://www.blogger.com/profile/15034512539732498064</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='33' height='24' src='http://1.bp.blogspot.com/_VPJfp9Gcn4A/SqfQem8ZR5I/AAAAAAAAAA0/rov6_RYmAos/S220/logoSingle_color.gif'/></author><thr:total>0</thr:total></entry></feed>
